Search research articles
Contact Us
Filters
Showing results (181-190 of 286) with videos related to
Page
of 29
Sort By:
The Journal of Clinical Psychiatry
|
August 20, 2009
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial
Oliver Freudenreich, David C Henderson, Eric A Macklin, et al.
Journal of Affective Disorders
|
February 19, 2021
Validation of brief screening measures for depression and anxiety in young people with substance use disorders
Kate H Bentley, Hitoshi Sakurai, Kelsey L Lowman, et al.
Schizophrenia Research
|
March 8, 2008
High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
Michael A Dyer, Oliver Freudenreich, Melissa A Culhane, et al.
American Journal of Preventive Medicine
|
October 10, 2025
Effects of Legalizing Recreational Cannabis Sales on Cannabis Use and Cannabis-Related Disorder Among Presentations to a Psychiatric Emergency Service
Cheryl Y S Foo, Kevin Potter, Abigail C Wright, et al.
The Journal of Clinical Psychiatry
|
November 9, 2018
One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory
Randi Melissa Schuster, Jodi Gilman, David Schoenfeld, et al.
Clinical Endocrinology
|
July 1, 1990
Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries
J M Holly, J A Eden, J Alaghband-Zadeh, et al.
Psychological Medicine
|
February 6, 2026
Impulsivity-related predictors of adolescent substance use initiation
Jodi Gilman, Kevin Potter, Jasmeen Kaur, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists
Donald C Goff, Corinne Cather, A Eden Evins, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 12, 2023
The Developmental Timing but Not Magnitude of Adolescent Risk-Taking Propensity Is Consistent Across Social, Environmental, and Psychological Factors
Brenden Tervo-Clemmens, Zuena A Karim, Sehyr Z Khan, et al.
Psychiatric Services (Washington, D.C.)
|
November 3, 2020
Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES
A Eden Evins, Robert West, Neal L Benowitz, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 286) with videos related to
Sort By:
Page
of 29
The Journal of Clinical Psychiatry
|
August 20, 2009
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial
Oliver Freudenreich, David C Henderson, Eric A Macklin, et al.
Journal of Affective Disorders
|
February 19, 2021
Validation of brief screening measures for depression and anxiety in young people with substance use disorders
Kate H Bentley, Hitoshi Sakurai, Kelsey L Lowman, et al.
Schizophrenia Research
|
March 8, 2008
High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
Michael A Dyer, Oliver Freudenreich, Melissa A Culhane, et al.
American Journal of Preventive Medicine
|
October 10, 2025
Effects of Legalizing Recreational Cannabis Sales on Cannabis Use and Cannabis-Related Disorder Among Presentations to a Psychiatric Emergency Service
Cheryl Y S Foo, Kevin Potter, Abigail C Wright, et al.
The Journal of Clinical Psychiatry
|
November 9, 2018
One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory
Randi Melissa Schuster, Jodi Gilman, David Schoenfeld, et al.
Clinical Endocrinology
|
July 1, 1990
Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries
J M Holly, J A Eden, J Alaghband-Zadeh, et al.
Psychological Medicine
|
February 6, 2026
Impulsivity-related predictors of adolescent substance use initiation
Jodi Gilman, Kevin Potter, Jasmeen Kaur, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists
Donald C Goff, Corinne Cather, A Eden Evins, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 12, 2023
The Developmental Timing but Not Magnitude of Adolescent Risk-Taking Propensity Is Consistent Across Social, Environmental, and Psychological Factors
Brenden Tervo-Clemmens, Zuena A Karim, Sehyr Z Khan, et al.
Psychiatric Services (Washington, D.C.)
|
November 3, 2020
Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES
A Eden Evins, Robert West, Neal L Benowitz, et al.
Page
of 29